- Home
- IMVT vs BLDR Comparison
IMVT vs BLDR Comparison
Compare IMVT & BLDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMVT | BLDR |
|---|---|---|
| Founded | 2018 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | RETAIL: Building Materials |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 8.0B |
| IPO Year | 2019 | 2005 |
Fundamental Metrics
Financial Performance| Metric | IMVT | BLDR |
|---|---|---|
| Price | $38.35 | $71.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 18 |
| Target Price | $33.00 | ★ $121.76 |
| AVG Volume (30 Days) | 951.3K | ★ 2.3M |
| Earning Date | 05-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $15,190,638,000.00 |
| Revenue This Year | N/A | $0.71 |
| Revenue Next Year | N/A | $4.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.32 | $65.10 |
| 52 Week High | $41.23 | $151.03 |
Technical Indicators
Market Signals| Indicator | IMVT | BLDR |
|---|---|---|
| Relative Strength Index (RSI) | 49.67 | 46.53 |
| Support Level | $37.53 | $65.10 |
| Resistance Level | $41.22 | $75.72 |
| Average True Range (ATR) | 1.47 | 3.47 |
| MACD | -0.38 | -0.39 |
| Stochastic Oscillator | 33.86 | 45.27 |
Price Performance
Historical ComparisonAbout IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.
About BLDR Builders FirstSource Inc.
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.